ACRS (STOCKS)
Aclaris Therapeutics, Inc.
$3.390000
-0.260000 (-7.12%)
Prev close: $3.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Neal S. Walker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $374.41M
- Employees
- 64
- P/E (TTM)
- -2.64
- P/B (TTM)
- 3.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.12 | $-0.14 | +0.0177 | +12.85% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.14 | +0.0055 | +4.06% |
|
Mar 2025 (Q1)
|
$-0.12 | $-0.12 | -0.0001 | -0.08% |
|
Dec 2024 (Q4)
|
$-1.01 | $-0.22 | -0.7871 | -353.12% |
Financial Statements
| Revenues | $15.74M |
| Benefits Costs and Expenses | $157.42M |
| Cost Of Revenue | $2.26M |
| Costs And Expenses | $169.06M |
| Gross Profit | $13.48M |
| Nonoperating Income/Loss | $11.64M |
| Operating Expenses | $166.79M |
| Research and Development | $45.09M |
| Other Operating Expenses | $121.71M |
| Operating Income/Loss | -$153.32M |
| Income/Loss From Continuing Operations After Tax | -$141.68M |
| Income/Loss From Continuing Operations Before Tax | -$141.68M |
| Net Income/Loss | -$141.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$141.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$141.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.58 |
| Diluted Earnings Per Share | -$1.58 |
| Basic Average Shares | 128,577,884 |
| Diluted Average Shares | 128,577,884 |
| Assets | $175.53M |
| Current Assets | $100.59M |
| Cash | $167.20M |
| Noncurrent Assets | $74.94M |
| Fixed Assets | $811.00K |
| Other Non-current Assets | $74.13M |
| Liabilities | $55.43M |
| Current Liabilities | $25.63M |
| Accounts Payable | $9.19M |
| Wages | $3.76M |
| Other Current Liabilities | $12.69M |
| Noncurrent Liabilities | $29.80M |
| Equity | $120.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $120.10M |
| Liabilities And Equity | $175.53M |
| Net Cash Flow From Operating Activities | -$42.92M |
| Net Cash Flow From Operating Activities, Continuing | -$42.92M |
| Net Cash Flow From Investing Activities | -$50.73M |
| Net Cash Flow From Investing Activities, Continuing | -$50.73M |
| Net Cash Flow From Financing Activities | $71.25M |
| Net Cash Flow From Financing Activities, Continuing | $71.25M |
| Net Cash Flow | -$22.40M |
| Net Cash Flow, Continuing | -$22.40M |
| Comprehensive Income/Loss | -$141.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$141.51M |
| Other Comprehensive Income/Loss | $170.00K |